Table 1 Clinical characteristics of the enrolled patients
Demographics | CHB (n = 85) | LC-B (n = 70) | LF-B (n = 79) |
|---|---|---|---|
Male/female | 64/21 | 42/28 | 65/14 |
Age (years), mean ± SD | 39.800 ± 14.900 | 48.330 ± 11.050 | 46.400 ± 10.000 |
HBeAg positive/negative | 47/38 | 26/44 | 30/49 |
HBV DNA (log10) IU/ml | 6.70 ± 1.45 | 6.06 ± 1.17 | 6.45 ± 1.35 |
Antivirus treatment (Y/N) | 62/23 | 56/14 | 68/11 |
ALT (IU/L) | 178.894 ± 205.229 | 61.043 ± 117.280 | 186.861 ± 270.105 |
AST (IU/L) | 116.865 ± 146.940 | 70.171 ± 114.080 | 172.730 ± 219.91 |
TBil (mmol/L) | 41.843 ± 72.044 | 38.336 ± 43.166 | 238.420 ± 139.550 |